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Abstracts / Urological Science 27 (2016) S36eS52S46Results: Total 48 patients with D'Amico intermediate- and high-risk CaP
were analyzed. The mean patient age, BMI, preoperative PSA, and Gleason
score at biopsy appears equivalent but there're signiﬁcant statistic higher
percentage of cT2c in control group and a trend of higher percentage of
cT3b in NHT group. Shorter operative time (153.5 minutes v.s. 113.3 mi-
nutes, p¼0.0002) and lesser amount of blood loss (147.08ml v.s. 93.75ml,
p¼0.131) were found in NHT group. The average period of biochemical
recurrence (BCR) was similar (5.33 months v.s. 6.54 months, p¼0.523) but
the overall BCR rate was signiﬁcantly lower in NHT group (87.5% v.s. 54.2%,
p¼0.026). In sub-group analysis, BCR rate was signiﬁcant lower in NHT
group if preoperative PSA level were between 10 to 20 ng/ml (66.67% v.s.
0%, p¼0.035) and >50 ng/ml (100% v.s. 55.56%, p¼0.018) while BCR rate
was 81.82% v.s. 80% (p¼0.916) in PSA 20-50 ng/ml. However, average
follow-up period was signiﬁcantly insufﬁcient in NHT group (49.46
months v.s. 20.29 months, p<0.001) although BCR usually happened in the
postoperative ﬁrst year in our study.
Conclusion: Neoadjuvant NHT followed by RaLRP seems to provide some
potential beneﬁts in shorter operative time, lesser amount of blood loss,
and lower rate of BCR during postoperative two years in patients with
intermediate- or high-risk localized CaP.
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PARTIAL CYSTECTOMY IN UROLOGICAL PRACTICE: A SINGLE CENTER
EXPERIENCE
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Purpose: Although partial cystectomy is not the gold standard treatment
for muscle-invasive bladder cancer, a solitary lesion in a suitable location is
amenable to segmental resection with adequate margins. On the other
hand, when advanced gynaecological or colorectal malignancy involves
the urinary bladder, partial cystectomy has its role in bladder preservation
for better quality of life. Thus we review our experience of treating pelvic
malignancy with partial cystectomy at our institution.
Materials and Methods: From 1991 to 2010, a total of 45 patients un-
derwent partial cystectomy as en bloc resection for urological and non-
urological pelvic malignancies. Fifteen of themwere pT1-3 bladder cancer,
mostly urothelial carcinoma. The other 30 patients had urinary bladder
invasion from colorectal or gynaecological cancers. We retrospectively
reviewed these cases to evaluate the oncologic control perioperative
morbidities, and quality of life after partial cystectomy.
Results: Five of 15 patients were lost to follow up, thus the median fol-
lowupwas 48.4months (50%male, mean age: 66.2). 5-year recurrence free
rate was 50% (5/10), median time to recurrence was ten months. Mortality
rate was 20% (2/10). In mortality cases, one patient is diagnosed with bone
metastases initially and another patient is later diagnosed with pT4N2Mx
after he received radical cystectomy.16 of 29 patients were diagnosed with
bladder invasion after formal pathological report, only one case had uri-
nary bladder recurrence in 7 months. One patient expired in 3 months due
to pneumonia, 14 patients were recurrence free in urinary bladder at least
1 year, mean recurrence free time is 5.54 years.
Conclusion: From our experience, partial cystectomy for bladder cancer
control is still controversial. Further prospective or large scale study is
needed. However, en bloc resection for non-urological pelvic malignancy
in bladder invasion is feasible for tumor control.
MP4-8.
OUTCOME OF LAPAROSCOPIC RADICAL PROSTATECTOMY WITH
INTENDED WIDE RESECTION IN PROSTATE CANCER PATIENTS WITH A
PREOPERATIVE SERUM PSA LEVEL > 50 NG/ML: A SINGLE SURGEON
EXPERIENCE
Yen-Hsi Lee 1, Henry Y. Lin 1, Chung-Hsien Chen 1, Yu-Chi Chen 1, Victor C.
Lin 1,2. 1Department of Urology, E-Da Hospital, Kaohsiung, Taiwan; 2 School
of Medicine for International Students, I-Shou University, Kaohsiung, TaiwanPurpose: Toassess theoutcomeofprostatecancerpatientswithpreoperative
prostate-speciﬁc antigen (PSA) levels over than 50 ng/ml who were treated
with laparoscopic radical prostatectomywith intended wide resection.
Materials and Methods: Total twelve patients from Jan. 2007 to Dec. 2015
with prostate cancer who underwent laparoscopic radical prostatectomy
with intended wide resection had an initial PSA level over than 50 ng/ml
were included in this study. Overall survival, cancer-speciﬁc survival and,
peri-operative and post-operative parameters and pathologic features, per-
centage of neoadjuvant hormone therapy, adjuvant therapy were analyzed.
Results: ThemeanserumPSA levelwas89.4 (50.6-191.0)ng/ml. Fourpatients
(33%) received neoadjuvant hormone therapy. Two patients were classiﬁed
as stage pT2, three as pT3a, four as pT3b and three as pT4. Three patients had
pelvis lymph nodemetastasis. Six patients (50%) received adjuvant hormone
therapy. Three patients had PSA failure and two received salvage radio-
therapy. Overall survival and cancer-speciﬁc survival were 100% and 100%,
respectively, during mean follow up of 3.9 years. Continence rate was 91.7%
and average recovery time was 62 (7-287) days. Potency rate was 8.3%.
Conclusion: The study showed a relatively feasible outcome for clinically
non-metastatic but locally advanced prostate cancer with PSA levels over
than 50 ng/ml treated by laparoscopic radical prostatectomy with inten-
ded wide resection.
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Purpose: Angiomyolipoma (AML) is a benign neoplasm composed of
varying admixtures of blood vessels, smooth muscle cells, and adipose
tissue. However, it often leads to spontaneous hemorrhagic, pain or he-
maturia if large size. Invasive interventions including embolization,
nephron-sparing surgery, or even nephrectomy were suggested for larger
tumor. Due to increase risk of bleeding in larger tumor during operation,
preoperation transcatheter arterial embolization (TAE) in larger tumor
maybe can make the surgery more smoothly and decrease intra-operation
blood loss. Hence, we are here to share our hospital’s clinical experience.
Materials and Methods: From March 2012 to November 2015, 13 cases of
large AML (tumor size S7cm) underwent the nephron-sparing surgery in
Chi Mei Medical Center. Preoperation transcatheter arterial embolization
wasperformed in 6 cases (TAEgroup) and theother 7 cases are not (Non-TAE
group). Patient demographics, tumor characteristics, intraoperative, and
postoperativedata including tumor size,warm ischemia time, andestimated
blood loss (EBL) were analyzed and compared between these two group.
Results: From March 2012 to September 2015, there were 5 male and 8
female patients met the inclusion criteria. The mean age was 46-year-old.
Most of them have the chief complaint of ﬂank pain (61.5%), because of
tumormass effect or rupture. The average tumor sizewas 11.7cm (7-22) and
the average nephrometry score was 8. In the TAE group, mean warm
ischemia time (WIT) was 5 min 02 sec and Non-TAE group was 11 min 32
sec. Mean blood loss was 1650ml (300-4000) in TAE group and 1900ml
(50~7200) inNon-TAE group. Themeanpost operation length of l staywas 5
days in TAE group and 6.4 days in Non-TAE group. In Non-TAE group, there
were 3 patient (43%) showed residual tumor during post op follow up im-
aging study and only 1 patient (16%) showed residual tumor in TAE group.
Conclusion: In large AML case, TAE before partial nephrectomy had
shorterWIT, decrease intra-operation blood loss, shorter length of stay and
fewer residual tumor than those did not performed TAE.
MP4-10.
DETECTING PRIMARY UPPER TRACT UROTHELIAL CANCER WITH BY
WHOLE BODY FDG PET/CT
Chien-Hui Ou, Wen-Horng Yang, Yung-Ming Lin. Department of Urology,
Medical College and Hospital, National Cheng-Kung, University, Tainan, Taiwan
Abstracts / Urological Science 27 (2016) S36eS52 S47Purpose: The study aimed to evaluate the possibility of applying 18F-
ﬂuorodeoxyglucose positron-emission tomography (FDG PET/CT) for
detecting upper tract cancer.
Materials and Methods: 37 patients who had undergone preoperative.
FDG PET/CT for their suspected upper tract urothelial cancer from January
2010 to December 2015, were retrospectively enrolled for comparisonwith
the postoperative histological ﬁndings of nephroureterectomy.
Results: The histological ﬁndings revealed 39 urothelial malignancies in
37 nephroureterectomy specimens. The sensitivity of FDG PET CT was
87.1% (34/39) in detecting the primary upper tract urothelial cancer. 2
patients without FDG PET/CT avid tumor were diagnosed with Ta, low
grade urothelial cancer. In two patients with two separated upper tract
tumors by histology of nephroureterectomy, only one avid tumor was
found in FDG PET/CT. In one patient with annular type T3 ureteral cancer,
no deﬁnite evidence of FDG-avid tumor was found in the ureter.
Conclusion: FDG PET/CT may serve as a feasible supplementary method
for the diagnosis of upper tract urothelial malignancies but may miss low
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Purpose: Renal AML is considered as a benign kidney tumor with hamar-
tomatous features.However, itoften leads tohemorrhagic complications such
asretroperitonealhematomaorhematuria if large size. Invasive interventions
includingembolization, nephron-sparing surgery, or evennephrectomywere
suggested for larger tumor. Robotic-assisted laparoscopic partial nephrec-
tomyhelps in reducing surgical time,warm ischemia time, surgical technique
difﬁculty, intraoperative blood loss comparing to traditional laparoscopic
partial nephrectomy. Retroperitoneal approach provides better identiﬁcation
to renal pedicle control; prevent bowel injury and sooner bowel recovery.
However, there was less literature in reporting the robotic-assisted laparo-
scopic partial nephrectomy via retroperitoneal approach for angiomyoli-
poma. Hence, we are here to share our hospital’s clinical experience.
Materials andMethods: In Chi-MeiMedical Center, we performed robotic-
assisted retroperitoneoscopic partial nephrectomysinceAugust 2012, there
were 15 patients met the surgical indication of angiomyolipoma (tumor >
4cm or symptomatic) and underwent the nephron-sparing surgery with
single surgeon, as the inclusion criteria. The tumor’s characteristic, intra-
operative statuses, post-operative follows up outcome were analysis.
Results: From august 2012 to September 2015, there were 3 male and 12
female patients met the inclusion criteria. The mean age was 53-year-old.
Most of themwere asymptomatic (86%) but larger tumor, the average tumor
sizewas 5.22cm (2.3-13). The average nephrometry scorewas 6.35; Console
time was 121mins (40e238); warm ischemia time was 15 min (5e28);
estimated blood loss was 550ml (100e1300). Only 2 (13%) of patients need
intraoperative transfusion; 2 (13%) patients need post-operative emboliza-
tion (grade 3a complication). The average post-operative estimated
glomerular ﬁltration rate loss was 24% (7e40). The mean length of hospital
staywas 4 days (2e8). Therewas no readmission ratewithin 30 days. Only 1
patient (6%) showed residual tumor during follow up imaging study
Conclusion: Robotic-assisted retroperitoneoscopic partial nephrectomy
has acceptable morbidity and outcomes, it is safe and feasible in patient of
benign renal angiomyolipoma.
MP5-2.
FEASIBILITY AND OUTCOMES OF RADICAL CYSTECTOMY FOR BLADDER
CANCER IN THE OLDER PATIENTS (AGE>65 Y/O)
Chao-An Chen, Wei-Yu Lin, Kuo-Hsiung Chiu, Yin-Lun Chang, Kuo-Cai
Huang, Jian-Hui Lin, Yung-Chin Huang, Dong-Ru Ho, Chih-Shou Chen,Tzu-Hsin Yang. Division of Urology, Department of Surgery, Chiayi Chang
Gung Memorial Hospital, Chiayi, Taiwan
Purpose: To report our experience with radical cystectomy by open or
laparoscopy method as applied to an older patient population with regard
to perioperative measures and pathologic outcomes.
Materials and Methods: A total of 48 patients underwent cystectomy and
extracorporeal urinary diversion at our institution from September 2008
through March 2016 for clinically localized bladder cancer. The clinical
characteristics, operative outcomes, and pathologic results of the consec-
utive cases were categorized by age (younger, age <65 years vs older, age
S65 years).
Results: The outcomes of the 21 younger and 27 older patients, including
10 patientsS 80 years old, were assessed. The number of patients received
cystectomy by open vs. laparoscopy method in the younger and older
groups were 7 vs. 14 and 12 vs.11, respectively. The numbers of different
urine diversions methods (young vs .old) were1vs. 5 (ureter-
ocutaneostomy), 10 vs. 10 (ileal conduit), 4 vs.6 (neobladder). No differ-
ences were observed between the 2groups in American Society of
Anesthesiologists score, operation time, blood loss, time to discharge,
complication rate, open conversion rate, 30-D and 90-D mortality rate.
Also, no signiﬁcant differences were found in the surgical pathologic
ﬁndings, including the organ-conﬁned rate and lymph node yield.
Conclusion: Older patients do not appear to have any signiﬁcant differ-
ences or compromises with regard to the perioperative and pathologic
outcomes after radical cystectomy by either open or laparoscopy method
and urine diversionwith or without neobladder. Thus age alone should not
preclude radical cystectomy or for certain type of urine diversion.
MP5-3.
PROGNOSTIC FACTORS OF THE UPPER TRACT UROTHELIAL CARCINOMA
PT3 PATIENTS. SINGLE CENTER EXPERIENCE 192CASES IN TAIWAN
Guan-Lin Huang, Hao-Lun Luo, Po-Hui Chiang. Department of Urology,
Kaohsiung Chang Gung Memorial Hospital, Taiwan
Purpose: Adjuvant therapy for post-operative locally advanced upper tract
urothelial carcinoma (UTUC) is still controversial. We are wondering if
there is any prognostic factors on the recurrence of T3 UTUC for clinical
decision on post-operative adjuvant therapy.
Materials and Methods: Medical records of 192 pT3 UTUC patients from
2005e2013 were reviewed. Collected variables as age, follow up time,
gender, tumor location, nodal status, smoking, grade, lymphovascular in-
vasion (LVI), ESRD, tumor subtype and recurrence. Multivariate analysis of
the prognostic factors on the tumor recurrence.
Results: 192 patients with median follow up duration 35.6 months were
analyzed. 95 patients (49%) with systemic recurrence were noted in the
follow up duration. Multivariate analysis of the risk factors for the recur-
rence showed signiﬁcance on nodal status, smoking and lymphovascular
invasion (LVI). We classiﬁed the patients into 3 groups as 1. lymph nodes
negative 2. lymph nodes negative with LVI or smoking 3.lymph nodes
positive. The Kaplan-Meier recurrence free survival curve showed signif-
icant difference on the 3 groups.
Conclusion: For patients with clinical PT3 UTUC, lymph nodes metastasis,
lympho-vascular invasion and smoking status were independent poor
prognostic factors. These results may be used to counsel patients towards
post-operative adjuvant therapy.
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LAPAROSCOPIC RETROPERITONEOSCOPIC PARTIAL NEPHRECTOMY
FOR RENAL ANGIOMYOLIPOMA
Chye-Yang Lim 1,2, Steven Kuan-Hua Huang 1, Kau Han Lee 1,2, Wei-Hong
Lai 2. 1Division of Urology, Department of Surgery, Division of Uro-
Oncology, Chi Mei Medical Center, Tainan, Taiwan; 2Division of Urology,
Department of Surgery, Ditmanson Medical Foundation Chia-Yi Christian
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Purpose: Nephron-sparing surgery for renal tumor was the standard
procedure for the resectable renal tumor in order to preserve renal func-
tion. It was evolved from open surgery to the minimal invasive surgery
